Wednesday, February 10, 2010, 2:25pm SGT - The Singapore stock market closes in 2 hours and 35 minutes.
To create a watchlist or portfolio of shares, Register
FINANCE HOME PAGEINVESTINGFINANCE NEWS
    Market:       |  

Genzyme Corp. (GENZ)

At 5:00AM SGT: 54.87 USD  Up 0.38 (0.70%)  
 MORE ON GENZ 
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
 Genzyme Corporation (NasdaqNM:GENZ) Delayed quote dataEdit
After Hours: 54.87 0.00 (0.00%) as of 5:31am SGT on 02/10/10
Last Trade:54.87 USD
Trade Time:5:00AM SGT
Change:Up 0.38 (0.70%)
Prev Close:54.49
Open:55.02
Bid:54.35 x 300
Ask:55.23 x 200
1y Target Est:55.53
Day's Range:54.27 - 55.47
52wk Range:47.09 - 73.75
Volume:2,267,418
Avg Vol (3m):3,449,710
Market Cap:14.56B
P/E (ttm):31.28
EPS (ttm):1.75
Div & Yield:N/A (N/A%)
[Chart]
1d  5d  3m  6m  1y  2y  5y  max 
Use Y! Toolbar to track stocks
 Add GENZ to Portfolio   Download Data

 HEADLINES 
•Targeted Genetics completes $7M Genzyme deal
at bizjournals.com (Wed 12:05am)
•Weekly Street Sentiment: Sell-Side Still Searching for Direction
at Seeking Alpha (Tue 5:52pm)
•PREVIEW-Genzyme competition may get clearer at conference
at Reuters (Tue 3:37am)
•GSK: Rare Diseases Now Big Business
at The Wall Street Journal Online (Mon, Feb 8)
•5 Beaten Down Stocks Ready For Reversal
at Investopedia (Sat, Feb 6)
•Biotech Stock Mailbag: Soligenix
at TheStreet.com (Fri, Feb 5)
•My Favorite Investor
at Motley Fool (Fri, Feb 5)
•Biotech Stocks: Pfizer leads drug stocks south
at MarketWatch (Thu, Feb 4)
•Pfizer's Hedge Pays Off
at Motley Fool (Thu, Feb 4)
•Genzyme names global manufacturing president
AP (Wed, Feb 3)
•UPDATE - Genzyme names ex-Lilly exec to head manufacturing
at Reuters (Wed, Feb 3)
•Ahead of the Bell: Genzyme upgraded to 'Buy'
AP (Wed, Feb 3)
More Headlines for GENZ...
 ANALYST 
EPS Est (next year) (Dec-09) :2.24
EPS Est (in 2 years) (Dec-10) :3.43
Avg Rec (current)*:2.4
PEG Ratio:1.17
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
Genzyme Corporation operates as a biotechnology company worldwide. The company’s Genetic Diseases segment manufactures and distributes therapeutic products, including Cerezyme as an enzyme replacement therapy for the treatment of Type 1 and T...

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Search by Company
•Latest News•Singapore Indices